Process for preparing cephalosporins

Abstract: The invention relates to an improved process for preparing cephalosporins by reaction compounds such as 7-amino -cephalosporanic acid, 7-amino-3-deacetoxy-cephalosporanic acid or their derivatives with derivatives of α-amino acids in the presence of a properly immobilized penicillin acylase enzyme under the following conditions, independently, or in combination: (1) at a temperature ranging from 0°C to +20°C; or (2) at ambient pH; with a high molar ratio of (α-amino acid to a cephalosporanic nucleus.

Description: FIELD OF THE INVENTION The present invention relates to an industrially advantageous improved enzymatic process for the preparation of cephalosporins by condensing the corresponding 7-amino cephalosporin nucleus with an α-amino acid. BACKGROUND OF THE INVENTION An enzymatic process for the preparation of cephalosporins by condensation of an amino acid derivative and an 7-amino cephalosporin nucleus is described in U.S. Patent No. 3,816,253. In most of the examples of this patent, the microorganisms which produce the enzyme are themselves added to the reaction mixtures as the enzyme source. A crude cell-free preparation and a preparation that has been subjected to two chromatography steps are also exemplified. The patent describes a 5° to 50°C temperature range for carrying out the reaction, with a 20° to 40° C range being most advantageous. However, in all but one of the examples, the reaction is carried out at 37°C. In the sole exception, the reaction is carried out at 25°C and achieves a reported 63% yield. When operating at the temperatures exemplified in the above patent, the yield of the desired product can be reduced by competing reactions which cause the formation of contaminating by-products, primarily a hydrolysis product of the amino acid derivative. These by-products cannot always be easily separated from the reaction mixture. However, irrespective of how easily the by-products can be removed, their presence increases the cost of production. Improved methods of making β-lactam antibiotics are disclosed in EP-A-473008, CH-A-640240, FR-A-2134530, FR-A-2255379, WO-A-9201061 and WO-A-9312250. As the enzymatic process has been applied in the past, substantial amounts of enzyme are consumed with each synthesis reaction. Thus, the cost of the enzyme is a substantial part of the cost of the process. An enzymatic process is disclosed in WO-A-9 312 250, falling under Article 54(3) and (4) EPC. Due to the current cost of operating the enzymatic process, it is not as commercially attractive as a conventional organic chemical process. However, the enzymatic process has a number of advantages over the organic chemical process that would be more important commercially if the cost of the enzymatic process were reduced. For instance, the enzymatic reaction process requires only one reaction step, while the organic chemical process requires several steps. Further, the organic chemical process is lengthy, uses substantial amounts of solvents such as pyridine and creates unwanted by-products. In view of the above, what is needed in the art is an enzymatic process that achieves yields as good as or better than those previously achieved enzymatically. SUMMARY OF THE INVENTION It has now been found that it is possible to increase the yield of the desired cephalosporin antibiotic product to higher levels than disclosed by prior art by carrying out a condensation reaction (as described below) at temperatures ranging from +20°C to 0°C in the presence of immobilized penicillin acylase in a suitable reaction medium/solvent. In one aspect, the process of the invention is directed to carrying out the condensation such that the pH is allowed to drift or change without intervention during the reaction. DESCRIPTION OF THE INVENTION The present invention provides a method of preparing cephalosporins of formula (I): wherein R is a five-or six-membered hydrocarbon ring which is unsubstituted or substituted with one, two or three substituents selected from the group consisting of hydroxy, halogen, alkyl, alkoxy, carboxy, nitro and amino, or R is a five-membered heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen or sulphur, which is unsubstituted or substituted with one to three substituents selected from the group consisting of hydroxy, halogen, alkyl, alkoxy, carboxy, nitro and amino; R 1 is a hydrogen atom, a halogen atom, a methoxy, a methyl or a methylene which is bonded to an organic radical directly or via an oxygen, sulphur or nitrogen atom, wherein the radical is an alkoxy, an alkoxycarbonyl or a five- or six-membered heterocyclic group containing one to four heteroatoms selected from O, S and N; and R 2 is hydrogen or a carboxy-protecting group; comprising reacting a compound of formula (III): wherein the hydroxy of the carboxylic moiety has been substituted with methyl, ethyl or benzyl; with a cephalosporin substrate of formula (II): in the presence of an effective amount of a penicillin acylase enzyme, and where the pH is allowed to drift or change without intervention during the reaction. Preferably the process of the invention is directed to carrying out the condensation using a high α -amino acid to cephalosporin molar ratio. The prior art enzymatic production of cephalosporins is characterized by the production of contaminating by-products and loss of enzyme during the production process. In a first embodiment of the present invention, the quantity of contaminants arising during production of these antibiotic compounds by employing a condensation reaction between a reactive derivative of an α -substituted α -amino acid of formula (III) with an 7-amino cephalospoprin substrate of formula (II) in the presence of an immobilized enzyme at a temperature ranging from about 0°C to about 20°C is reduced. At low temperatures, the activity of enzymes is generally depressed, often markedly so. To meet this problem the present invention generally uses greater amounts of enzyme. By this approach, favorable product yields are achieved at very low temperatures, e.g., 0°C to 5°C. In the practice of this bio-catalytic condensation process, a maximum product concentration is achieved after a period of time which varies based on enzyme amount, substrate, temperature, and other variables which will be known to those of ordinary skill in the art. Thereafter, the concentration of product remains constant for a period of time approximately proportional to the time required to achieve maximum product concentration. For instance, if the maximum product concentration is achieved in about two hours, the plateau concentration lasts for about one hour. Afterwards, the product concentration usually decreases. In practicing the invention, it is preferred to employ that quantity of penicillin acylase enzyme that results in a stable product concentration (or plateau concentration) that lasts for about one hour so that there is enough time to remove the product from the reactor. However, a plateau period of between about 10 min. and about 120 min., more preferably between about 30 and about 80 min., should be useful in practicing the invention. In the invention, the pH is allowed to remain ambient, ie., drift or change without intervention during the reaction, or, in other words, is not kept constant by means such as a buffered solution. Normally, the pH is set at about 7-7.5 and is allowed to drop during the reaction to a pH of 6-7. While not wishing to be bound by theory, it is believed that under ambient pH, the hydrolysis of PGME and the final product are reduced compared with the rate of formation of the final product. Generally, in all embodiments of the invention, the amount of enzyme used is 50-3000 IU enzyme per gram of 7-amino cephalosporin substrate (II). Of course, it will be recognized by those of ordinary skill in the art that the amount of enzyme favorably used in the process will vary, for instance, with the nature and quality of the substrate, with the scale of the reaction, with the temperatures used, and with the type of apparatus used. With respect to the above formulas, R may be: a five- or six-membered aliphatic or aromatic hydrocarbon ring (e.g., phenyl, cyclohexadienyl, cyclohexenyl or cyclohexyl) optionally substituted with one or more radicals including but not limited to hydroxyl, halogen, alkyl, alkoxyl, carboxyl, nitro, amino, and the like; or it can be a five-membered heterocycle containing one or more heteroatoms (preferably no more than four) selected from O, N and S or combinations thereof (e.g., thienyl, furyl, and the like), which heterocycle may be substituted by one or more radicals (preferably no more than three) including but not limited to hydroxyl, halogen, alkyl, alkoxyl, carboxyl, nitro, amino, and the like. Particularly preferred are product compound (I) and corresponding formula (III) compounds where R is an unsubstituted phenyl, a p-hydroxyphenyl, or a 1,4-cyclohexadien-1-yl radical. When R is a heterocyclic radical, it is anticipated that the 4-thiazolyl, furyl and thienyl radicals can be advantageously employed. R 1 , in turn, can be a hydrogen atom, a halogen atom (Br, Cl, I, F), a methoxy, a methyl or a methylene bonded to an organic radical such as a C 1 -C 6 alkoxy, a C 1 -C 6 alkoxy-carbonyl or a five-or six-membered heterocyclic group containing one to four heteroatoms selected from O, S and N or combination thereof, the methylene group being optionally bonded to the radical via a bridging atom of O, S or N, the heterocyclic group may also optionally bear substituents such as one or more radicals including (without limitation): hydroxy, halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, carbonyl, carboxy, cyano, amino, nitro and the like. Particularly preferred R 1 are methyl, methoxy, chloro, and acetoxymethylene. Preferred heterocyclic radicals for R 1 (exclusive of the methylene and heteroatom by which the heterocycle may be attached to the lactam ring system) are the 1H-1,2,3-triazol-4-yl, 1H-tetrazol-5-yl and 2-thiazolyl radicals. The reactive derivatives of α -substituted α-amino acids which can be used in the invention are those derivatives at the carboxyl moiety wherein the hydroxy of the carboxylic moiety has been substituted with an organic group which can be hydrolyzed to re-create the carboxylic acid by exposure to the penicillin acylase which is to be employed in the condensation. While not wishing to be bound by theory, it is believed that this experiment identifies those derivatives which can react with the enzyme to form a reactive acyl-enzyme intermediate which can then react and form an amidic bond with the 7-amino cephalosporin nucleus of formula (II). Useful examples of reactive derivatives of the α -amino acid of formula (III) are alkyl esters (e.g. methyl esters, ethyl esters), aralkyl esters (e.g. benzyl esters), amides and dipeptides (i.e., amides formed with a second amino acid). The methyl esters of D-phenyglycine, D-p-hydroxyphenylglycine, and D-1,4-cyclohexadien-1-yl-glycine are preferred examples. Other examples of carboxy protecting groups (R 2 ) may be found in U.S. Patent No. 4,892,942, or E. Haslam, Protective Groups in Organic Chemistry, J. G. W. McOmie, Ed., Plenum Press, N.Y., N.Y., 1973, Chapter 5, and T. W. Greene, Protective Groups in Organic Synthesis, John Wiley & Sons, N.Y., N.Y., 1981, Chapter 5. The following acids are of particular interest among the compounds of formula (II): 7-aminocephalosporanic acid, 7-amino-3-deacetoxy-cephalosporanic acid, and 7-amino-3-chloro-cephalosporanic acid. The penicillin acylase enzyme used in the process according to the present invention may be derived from any of the known microbial sources. Among these are micro-organisms of the Xanthomonas, Pseudomonas, Aeromonas, Escherichia, Arthrobacter, Corynebacterium and Bacillus genera. The use of penicillin acylase derived from Escherichia Coli ATCC 9637 is particularly preferred. The process according to the present invention is preferably carried out in the presence of an immobilized enzyme. The immobilization can be done by any one of a number of well-known immobilization techniques, such as: absorption, ionic or covalent bond to polymer matrices, cross-linking, trapping in gel or fibers, microencapsulation or entrapment behind an ultrafiltration membrane in a membrane reactor (i.e., membrane partition). Use of an enzyme incorporated into cellulose triacetate fiber structures or covalently bonded to polyacrylamidic resin is preferred. Immobilized penicillin Acylase, either fiber entrapped or covalently bonded to a polymeric matrix is commercially available from Recordati, S.p.A., Biochemical Unit De.Bi., Cassina de Pecchi, Italy. The compound of formula (II) is reacted in concentrations of about 0.5 to about 2% (wt/v), preferably 1.4 to 1.5%. In another embodiment of the invention, the reactive derivatives of formula (III) are reacted in high molar ratios (between about 3 to about 5) based on the amount of compound of formula (II). While the reaction may be carried out at a temperature ranging from about 0°C to about +20°C, temperatures in the range of 0 to 2°C are preferred. A preferred solvent system is water only. However, suitable organic solvents include ethylene glycol, lower alcohols (e.g., methanol, ethanol, iso-propanol, 2-butanol), acetone and the like, which may be used in the aqueous system. During the course of the reaction process according to the present invention, the extent of reaction and product quality may be monitored by high performance liquid chromatography (HPLC) and other known methods. The following examples will better explain the characteristics and applicability of the invention, but will not limit its scope. To illustrate the invention, 7-amino-3-chlorocephalosporanic acid ("7-ACCA") is used as the cephalosporin substrate. 7-ACCA can be prepared as described by R. R. Chauvette et al., J. Med. Chem. 18 :403 (1975). D-phenylglycine methyl ester ("PGME") and D-p-hydroxyphenylglycine methyl ester ("HPGME") can be prepared from commercially available amino acids (e.g. from SIGMA) using standard esterification procedures such as treatment with methanol in the presence of HCl. This and other classical methods of derivatizing amino acids are described in Survey of Organic Synthesis, by C. A. Buehler and D. E. Pearson, Wiley-Interscience, New York, 1970, Vol 1, pp. 801-830 and in Vol. 2 (1977), pp. 711-726. Example 1 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4 -carboxylate, inner salt (1) 7-ACCA (1) (0.9388 g, 4.0007 mmol) and 96.0 ml of H 2 O are combined in a beaker. The pH is 4.12. Three molar NH 3 (1.78 ml) is added to the beaker. The pH is 7.57. D-phenylglycinemethyl ester hydrochloride (2) (4.7594 g, 23.602 mmol) is added to the beaker. The pH is 5.68. The mixture is cooled to 5°C, and three molar NH 3 (1.90 ml) is added to the mixture to raise the pH to 7.00. Enzyme (6.1442 g, 940 IU/g of nucleus) is added. The following reaction rate data, via HPLC analysis, is provided: Time (Min) pH Temp(°C) Compound 1 % remaining Compound 2 % remaining Compound 3 % formed 0 7.00 6 100 100 - 85 6.28 5 9.2 67.1 91.4 120 6.16 4 9.1 64.3 91.5 180 5.97 4.5 8.9 63.7 91.8 200 5.91 4.5 8.8 65.3 93.0 At time = 200 minutes, the mixture is filtered (to remove the immobilized enzyme) with an in situ yield of the titled product being 93%. Comparative Example 2 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt (1) 7-ACCA (1.0072 g, 4.000 mmol) and purified H 2 O (550 ml) are combined in a beaker. The pH is 3.39. Three molar NH 3 (4.10 ml) is added to the mixture. The pH is 6.73. D-phenylglycine-methylester hydrochloride (4.8397 g, 24.000 mmol) is added to the mixture. The pH is 6.5. The mixture is diluted to 75.09 ml with H 2 O (13.77 ml). Wet enzyme (3.0672 g, ~470 IU/gm nucleus) is added to the mixture. (During experiment, the pH is adjusted up to 6.5 every 30 minutes). The following data is provided via HPLC: Time (Min) pH Temp(°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 6.48 6 95.9 100 - 30 6.34 5.5 53.0 87.0 32.5 60 6.39 5.5 36.0 82.3 48.9 90 6.41 5 24.2 79.6 59.7 120 6.41 5.5 17.6 73.2 66.3 210 6.38 3.5 9.0 69.5 78.5 240 6.37 5 8.0 67.8 80.8 270 6.38 4.5 6.9 66.3 82.3 300 6.42 4.5 6.8 61.7 80.8 330 6.42 4.0 6.2 61.0 80.1 350 6.42 5 7.1 47.7 88.2 After 350 minutes, the mixture is filtered, with the in-situ yield of the titled product being 88.2% Example 3-17 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt For examples 3 to 17, the following general procedure is employed: (1) 7-ACCA (1.0072 g, 4.00 mmol) is combined with H 2 O. The pH of the mixture is adjusted with three molar NH 3 to obtain a solution. A designated amount of D-phenylglycine methylester hydrochloride is added, as indicated in the table below. The mixture is cooled to 5°C. Three molar NH 3 is then added in an amount to obtain the pH as indicated in the Table below. The mixture is diluted with H 2 O to the concentration as designated in the Table below. Wet enzyme (3.07 g,500 IU/gm nucleus) is then added. The pH is not adjusted except when the starting pH is 6.5, wherein the reaction pH is maintained between 6-2-6.5. Reaction Conditions: a) 1.0 eq. D-phenylglycine methylester hydrochloride b) 3.5 eq. D-phenylglycine methylester hydrochloride c) 6.0 eq. D-phenylglycine methylester hydrochloride d) 0.5 concentration e) 1.25 concentration f) 2.0 concentration g) 6.5 starting pH (upon addition of enzyme) h) 7.25 starting pH (upon addition of enzyme) i) 8.0 starting pH (upon addition of enzyme) Example Reaction Conditions Time (Min.) Product Yield 3 C,F,H 150 86.9 4 C,D,H 150 80.6 5 A,F,H 275 46.6 6 A,D,H 180 28.9 7 C,E,I 60 83.4 8 C,E,G 330 84.7 9 A,E,I 45 34.3 10 A,E,G 540 42.8 11 B,F,I 60 79.8 12 B,F,G 360 78.9 13 B,D,I 60 56.2 14 B,D,G 630 70.8 15 B,E,H 180 80.4 16 B,E,H 190 81.0 17 B,E,H 180 80.8 Example 18 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt (1) 7-ACCA (4.8338 G, 20 mmol) is combined with H 2 O (150 ml). The pH is 3.67. Three molar NH 3 (8.40 ml) is added to the mixture. The pH is 8.20. D-phenylglycine methyl ester (23.0 g, 114 mmol) is added to the mixture. The pH is 5.29. The mixture is filtered through filteraid and diluted with 100 ml H 2 O. The volume of solution is 310 ml. Water (5 ml) is added and the solution is cooled to 1°C. The pH is 5.80. The pH is adjusted to 7.28 with three molar NH 3 (16.6 ml). The volume is 332 ml. Water washed enzyme (15.34 g) is added. The following is provided, via HPLC analysis: Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 7.28 2 96.0 94.5 - 90 6.94 1 8.1 61.5 87.7 120 6.83 1 6.6 56.0 84.8 145 6.76 1 7.1 58.5 89.8 Example 19 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt (1) 7-ACCA (0.494 g, 2.000 mmol) and 42.0 ml of 0.0033 M K 2 HPO 4 pH 6.5 buffer are placed in a beaker. The pH is 5.91. To the solution, 45% K 3 PO 4 (eq) (0.92 ml) is added to dissolve. The pH is 7.24. D-phenylglycine methylester hydrochloride (2.3797, 11.801 mmol) (2) is added. The pH is 6.40. 45% K 3 PO 4 (1.10 ml) is added to obtain a pH of about 7.0. Enzyme (2.6120 g, 800 IU/g nucleus) is added. At T = 43 minutes, the pH is adjusted to 7.00 with 1.34 ml of 45% K 3 PO 4 . The maximum yield of the titled product is 66.1%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 6.95 0.25 93.6 95.1 0.0 5 6.72 26.5 32.0 66.8 54.8 10 6.62 27.5 20.6 55.7 64.0 15 6.50 28 17.6 48.8 66.1 20 6.36 28.5 16.6 42.8 64.5 25 6.27 28.5 16.6 40.3 64.5 30 6.18 29 17.0 37.9 64.1 35 6.10 29 17.0 36.6 64.8 40 6.03 29.5 17.3 34.2 61.6 45 6.95 29.5 - 30.6 59.9 50 6.84 29.5 24.5 22.8 53.7 55 6.75 30 27.3 17.9 49.1 60 6.68 60 29.1 14.3 45.2 Example 20 7-(D-2-ammonium-2-phenylacemaido)-3-chloro-3-cephem-4-carboxylate, inner salt The experiment of Example 19 is run except that 2.2707 g of dried enzyme (2660 IU/g nucleus) is used. No adjustment is made to pH during the reaction. The maximum yield is 67.5%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % 0 7.00 23.5 99.6 99.4 - 5 6.95 24 62.7 80.8 275 10 6.88 25 40.2 74.1 49.0 15 6.85 25 30.1 68.6 58.5 20 6.78 25.5 22.2 63.7 63.7 25 6.71 26 18.0 58.5 66.1 30 6.65 26.5 16.8 55.6 67.5 35 6.59 27 15.5 51.7 66.8 40 6.54 27 15.5 49.8 66.5 45 6.49 27 16.7 46.3 65.5 50 6.44 27.5 16.2 44.8 64.8 55 6.38 27.5 16.2 42.8 63.5 60 6.34 28 16.2 41.4 63.2 180 5.75 27 17.4 32.7 50.8 Example 21 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt The experiment as recited in Example 19 is ran with the following changes: Compound 1 used: 0.4698 g, 2.002 mmol Compound 2 used: 2.381 g, 11.8074 mmol 0.033 MK 2 HPO 4 /pH 6.5 buffer used: 44.0 ml 45% K 3 PO 4 used: 0.95 ml/1.06 ml Wet enzyme used: 8.1686 g, 2660 IU/g of nucleus The pH is adjusted to 7.00 with 1.37 ml of 45% K 3 PO 4 at T = 52 minutes. The maximum yield is 65.6%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 7.00 23.5 95.7 95.6 - 5 6.72 24 19.9 51.9 61.9 10 6.45 25 17.1 40.9 65.6 15 6.26 25 17.8 36.2 65.6 20 6.11 25.5 18.1 32.4 63.5 25 5.99 26 18.7 31.3 62.2 30 5.88 26 19.5 30.4 62.7 35 5.81 26.5 19.7 29.6 61.9 40 5.73 26.5 20.0 28.9 61.1 45 5.66 27 20.1 28.3 59.5 50 5.61 27 20.6 28.5 60.4 55 6.90 27 29.6 17.6 49.2 282 6.16 28 74.1 - 0.9 Example 22 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt 7-ACCA (0.470 g, 2.0058 mmol) (1) and 48.0 ml of 0.033 M K 2 HPO 4 (pH 6.5 buffer) are placed in a beaker. The pH is 5.73. The beaker is placed in a bath at 20°C. 45% K 3 PO 4 (1.06 ml) is added to dissolve. The pH is 7.21. D-phenylglycine methylester hydrochloride (2.3811 g, 11.8099 mmol) (2) is added to the solution. The pH is 6.60. 45% K 3 PO 4 (0.71 ml) is added to result in a pH of 7.00. Wet enzyme (3.0727 g) is added. The maximum in situ yield of the product is 74.6%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % 0 7.00 20.5 100 100 - 5 6.89 20.5 43.4 76.1 48.7 10 6.78 20.5 25.4 62.0 62.1 15 6.68 21 21.8 59.5 71.0 20 6.60 21 20.1 56.0 74.0 25 6.52 21 18.9 52.2 73.5 30 6.45 21 18.6 49.1 72.0 35 6.40 20.5 19.1 47.8 74.6 40 6.35 20.5 19.0 46.9 73.4 45 6.31 21 18.7 44.2 71.2 50 6.27 20.5 19.3 46.0 72.9 55 6.22 21 19.5 44.5 72.5 60 6.19 21 19.8 43.7 72.4 Example 23 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt 7-ACCA (0.4710 g, 2.0071 mmol) (1) and 48.0 ml of 0.033 M K 2 HPO 4 (pH 6.5) are added to a beaker. The pH is 6.02. 45% K 3 PO 4 (0.98 ml) is added to dissolve. The pH is 7.34. D-phenylglycinemethylester hydrochloride (2) (2.3801 g, 11.803 mmol) is added to the solution. The pH is 6.58. The beaker is placed in a bath (20°C). 45% K 3 PO 4 (0.63 ml) is added to adjust the solution pH to 7.00. Wet enzyme (3.0738 g) is added. The maximum yield of the titled product is 70.1%. [note to table: for times from 5 minutes to 50 minutes, small portions of 45% K 3 PO 4 are added 1 minute prior to the 5 minute period to bump the pH of the solution to about 7.00]. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % 0 6.99 19.5 99.3 98.7 - 5 7.01 20 52.2 80.6 36.3 10 7.02 20 33.9 69.4 57.7 15 7.00 20 24.4 60.4 63.1 20 7.00 20 20.6 55.1 67.1 25 7.00 20 20.1 51.9 69.6 30 7.00 20 19.7 47.4 70.1 35 7.00 20 20.3 43.5 68.7 40 7.03 20 21.3 39.9 67.9 45 7.00 20 22.2 36.7 66.2 50 7.01 20 23.8 33.5 65.7 140 6.58 20 37.2 14.4 50.2 240 6.41 20 38.0 11.1 44.1 Example 24 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt 7-ACCA (0.4696 g, 2.0012 mmol) (1) and 48.0 ml of H 2 O are placed in a beaker. The pH is 3.5. The solution is cooled to 10°C. Three molar NH 3 (2.47 ml) is added. The pH is 7.10. D-phenylglycinemethylesterhydrochloride (2.3835 g, 11.8198 mmol) is added. The pH is 5.65. Three molar NH 3 (4.30 ml) is added. The pH is 7.00. Wet enzyme (3.0778 g, 1000 IU/g nucleus) is added. [At T = 256 minutes, the pH is adjusted to 7.00 with 2.60 ml of 3M NH 3 ]. The maximum yield is 71.1%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 6.98 10 97.0 96.7 - 5 6.89 10 55.9 81.8 33.6 10 6.80 10 36.3 76.0 52.0 15 6.73 10 27.3 71.0 58.3 20 6.65 10 22.3 69.5 61.8 25 6.56 10 19.3 69.3 68.3 30 6.50 10 17.3 67.9 70.5 35 6.44 10 15.7 65.4 71.1 40 6.37 10 14.2 62.5 62.5 45 6.31 10 14.1 64.0 64.0 50 6.27 10 13.6 65.7 65.7 55 6.22 10 13.0 63.4 63.4 75 6.07 10 12.0 62.8 62.8 236 5.50 10 10.9 61.4 61.4 257 7.00 10 10.9 59.5 59.5 276 6.64 10 11.5 51.1 51.1 313 6.25 10 11.1 45.6 45.6 Example 25 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt 7-ACCA (0.4694 g, 2.0003 mmol) (1) and 48.0 ml of H 2 O are placed in a beaker. The pH is 3.25. The solution is cooled to 10°C. Three molar NH 3 (3.05 ml) is added. The pH is 7.08. D-phenylglycine methyl ester hydrochloride (2) (2.3809 g, 11.8069 mmol) is added. The pH is 5.40. Three molar NH 3 (7.24 ml) is added to result in a pH of 7.00. Wet enzyme (8.1840 g, 2670 IU/g nucleus) is added. [At T = 37 minutes, three molar NH 3 (1.72 ml) is added to adjust the pH to 6.52. At T = 298 minutes, three molar NH 3 (1.72 ml) is added to adjust the pH to 6.55). The maximum yield is 71.2%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 7.00 10 98.6 97.0 - 5 6.75 10 22.3 58.7 59.9 10 6.46 10 14.1 49.0 71.2 15 6.20 10 12.5 43.6 68.3 20 5.98 10 11.8 42.3 69.1 25 5.80 10 12.4 41.1 69.1 30 5.70 10 12.6 41.8 69.7 35 5.58 10 12.4 40.6 68.9 40 6.52 10 13.0 38.6 70.1 45 6.14 10 13.6 33.7 66.9 50 5.96 10 13.9 33.3 67.4 55 5.80 10 14.7 33.2 68.0 60 5.69 10 14.8 32.5 67.6 121 5.11 10 15.1 31.0 67.8 300 6.55 10 16.9 28.9 66.1 Example 26 7-(D-2-ammonium-2-phenylacetamido)-3-chloro-3-cephem-4-carboxylate, inner salt 7-ACCA (1) (0.4698 g, 2.002 mmol) and 48.0 ml of H 2 O are added in a beaker. The pH is 3.46. Three molar NH 3 (3.50 ml) is added. The pH is 7.23. D-phenylglycine methyl ester hydrochloride (2) (2.3798 g, 11.8015 ml) is added. The pH is 5.48. The mixture is cooled to 5°C. Three molar NH 3 (4.33 ml) is added to adjust the pH to 7.00. Wet enzyme (3.0710 g, 1000 IU/g nucleus) is added (At T = 295 minutes, 2.87 ml of three molar NH 3 is added to result in a pH of 7.00). The maximum yield is 79.5%. Time (Min.) pH Temp (°C) Compound 1 % remaining Compound 2 % remaining Product % formed 0 7.03 5 95.3 94.8 - 5 6.82 5 34.6 74.3 55.2 30 6.63 6 19.8 67.4 67.8 45 6.49 5 15.3 64.0 69.9 80 6.20 5 12.0 62.3 73.6 105 6.06 5.5 11.4 62.0 74.6 120 6.04 4.5 10.9 61.0 73.8 150 5.92 5 10.8 60.6 75.9 180 5.81 6 10.7 61.7 77.0 215 5.73 5.5 10.2 59.9 74.3 240 5.69 5.5 10.4 62.1 75.9 270 5.63 6 10.4 62.2 76.3 300 6.96 6 10.3 58.9 76.4 330 6.61 5.5 10.5 52.8 79.5

Claims: A method for preparing cephalosporins of formula (I): wherein R is a five- or six-membered aliphatic or aromatic hydrocarbon ring which is optionally substituted with one or more radicals selected from the group consisting of hydroxyl, halogen, alkyl, alkoxy, carboxy, nitro and amino, or R is a five-membered heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen or sulphur, which is unsubstituted or substituted with one to three substituents selected from the group consisting of hydroxy, halogen, alkyl, alkoxy, carboxy, nitro and amino; R 1 is a hydrogen atom, a halogen atom, a methoxy, a methyl or a methylene which is bonded to an organic radical directly or via an oxygen, sulphur or nitrogen atom, wherein the radical is an alkoxy, an alkoxycarbonyl or a five- or six-membered heterocyclic group containing one to four heteroatoms selected from O, S and N; and R 2 is hydrogen or a carboxy-protecting group; comprising reacting a compound of formula (III): wherein the hydroxy of the carboxylic moiety has been substituted with methyl, ethyl or benzyl; with a cephalosporin substrate of formula (II): in the presence of an effective amount of an immobilised penicillin acylase enzyme at a temperature ranging from 0°C to +20°C, and where the pH is set at about 7-7.5 and is allowed to drift or change without intervention during the reaction.

Inventors: GARDNER JOHN PAUL, GARDNER, JOHN PAUL
Applicants: LILLY CO ELI, ELI LILLY AND COMPANY
Application year: 1993
Main classification: C12P35
IPC codes: C07D501, C12P35